Improving Neurological Health in Aging Via Neuroplasticity-based

Status Completed

Clinical Trial Summary

This study is a validation study to evaluate efficacy of a neuroplasticity-based, computerized cognitive training program INHANCE (Improving Neurological Health in Aging via Neuroplasticity-based Computerized Exercise) to improve neurological and neuropsychological health in older adults.

Clinical Trial Description

The primary objective of this study is to evaluate the impact of a targeted speed and alertness training program (INHANCE) to improve cognition in healthy older adults, as evidenced by standard measures of cognition, and positive improvements in the neuromodulatory cholinergic system as measured via positron-emission tomography (PET). The investigators will employ a double-blind, parallel-arm, placebo-controlled, randomized clinical trial design comprised of a treatment group using INHANCE, a computerized program that trains speed of processing and attention, compared to an active control group using computer games in 92 healthy older adults. Approximately 108 participants will be consented to ensure the successful completion of 92 participants (post 20% attrition). Participants will then complete the Screening (V0) assessments to determine eligibility. Following inclusion, participants will complete the Baseline (V1) assessments, PET imaging and structural MRI scan; participants will then be randomized into either the INHANCE training or Computer Games, and will engage in approximately 35 hours of program use for the 10-week intervention period. Approximately halfway through the intervention period (~5 weeks), participants will complete Interim (V2) assessments to be compared to the Post-Intervention assessments. Following the 10-week intervention, participants will complete a Post-Intervention (V3) assessment and PET imaging to evaluate changes in cognitive function. Participants will then stop using their assigned program for 3 months and return for a Follow-up (V4) end-of-study assessment to evaluate the endurance of changes in cognitive function in the absence of further program use. The protocol will be conducted in accordance with the protocol submitted to and approved by the National Institute on Health (NIH), and subject to Institutional Review Board review and approval prior to implementation. ;

Study Design

Related Conditions & MeSH terms

Healthy Aging

Clinical Trial Details

NCT number	NCT04149457
Study type	Interventional
Source	Posit Science Corporation
Contact
Status	Completed
Phase	N/A
Start date	July 16, 2021
Completion date	June 7, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05596474` - Effect of Beet-root Juice and PBM Treatments on Muscle Fatigue	N/A
Active, not recruiting	`NCT05203848` - Community Dance Program (CDP) for Older Adults	Phase 1
Not yet recruiting	`NCT06455982` - Reduced Carbohydrates + Ketogenic Supplement on Energy Metabolism	N/A
Completed	`NCT04084457` - Investigating the Effects of Daily Consumption of Blueberry (Poly)Phenols on Vascular Function and Cognitive Performance	N/A
Recruiting	`NCT05006261` - A Mobile Tai Chi Platform for Fall Prevention in Older Adults - Phase II	N/A
Active, not recruiting	`NCT04262674` - Non-invasive, Wearable Multi-parameter System for the Early Prediction of Cognitive Decline and Dementia in Older Adults	N/A
Completed	`NCT02218411` - Video-supported Group-based Otago Exercise Programme on Physical Performance in Older Adults.	Phase 1
Active, not recruiting	`NCT05961319` - Smart Home Technologies for Assessing and Monitoring Frailty in Older Adults
Completed	`NCT05213091` - The Effect of Otago Exercises in the Elderly	N/A
Active, not recruiting	`NCT04904068` - Functional Neuroimaging in Parkinson's Disease
Completed	`NCT04348162` - Food Anthocyanins and Flavanols as a Strategy for a Healthy Ageing: Cardiovascular Health and Cognitive Performance	N/A
Completed	`NCT05941143` - Effect of Mindfulness on EEG Brain Activity for Cognitive and Psychological Well-being in the Elderly	N/A
Completed	`NCT06022094` - Effect of a Two-month Carbohydrate-restricted Diet on Energy Metabolism in a Seniors' Residence	N/A
Active, not recruiting	`NCT06162871` - Social Participation and Healthy Aging	N/A
Completed	`NCT05207501` - Effects of Different Moderate-intensity Exercise Methods on Health in the Elderly	N/A
Recruiting	`NCT04986787` - Novel, Individualized Brain Stimulation, Network-based Approaches to Improve Cognition	N/A
Completed	`NCT05933798` - China Pilot of ICOPE (Integrated Care for Older People) in Chaoyang	N/A
Recruiting	`NCT05394363` - Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
Completed	`NCT04786665` - Strawberries, Cognition, and Vascular Health	N/A
Completed	`NCT05290571` - Modified Otago Exercise Program on Balance Performance	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Improving Neurological Health in Aging Via Neuroplasticity-based Computerized Exercise — INHANCE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms